AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ENTECAVIR MONOHYDRATE
4 registrations across 3 African markets— 4 active
Markets with ENTECAVIR MONOHYDRATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Entavir 0.50 Tablets Tablet Uncoated | 🇿🇲Zambia | Drug International Limited | active | Jun 2030 |
| HEPWIN TABLETS (Each tablet contains Entecavir monohydrate 0.5mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| HEPWIN TABLETS (Each tablet contains Entecavir monohydrate 0.5mg) | 🇬🇭Ghana | — | active | Nov 2026 |
| ERTIVIX comprimé pelliculé / 1 mg | 🇸🇳Senegal | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | — |
ENTECAVIR MONOHYDRATE in Africa — Regulatory Overview
ENTECAVIR MONOHYDRATE is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Senegal, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 4 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.